444 filings
Page 13 of 23
6-K
CLLS
Cellectis
17 Apr 19
Cellectis Announces Oral and Poster Presentations of Allogeneic CAR T-Cell Programs at the 2019 ASGCT Annual Meeting
4:27pm
6-K
CLLS
Cellectis
2 Apr 19
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
4:30pm
6-K
CLLS
Cellectis
12 Mar 19
Cellectis Reports 4th Quarter
12:00am
20-F
2018 FY
CLLS
Cellectis
Annual report (foreign)
11 Mar 19
9:54pm
6-K
CLLS
Cellectis
7 Mar 19
Cellectis Enters Lease Agreement to Build Manufacturing Facility, Advancing Towards Commercialization of its UCART Portfolio
4:32pm
6-K
CLLS
Cellectis
26 Feb 19
Cellectis Publishes Novel Methods to Improve the Safety of CAR T-Cell Therapy and Prevent CRS in the Journal of Biological Chemistry
12:00am
SC 13G/A
FMR LLC
13 Feb 19
Cellectis S.A.
11:48am
6-K
CLLS
Cellectis
10 Dec 18
Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
4:31pm
6-K
CLLS
Cellectis
13 Nov 18
Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018
4:30pm
6-K
CLLS
Cellectis
13 Nov 18
Current report (foreign)
2:11pm
424B3
CLLS
Cellectis
15 Oct 18
Prospectus supplement
12:00am
S-8
CLLS
Cellectis
5 Oct 18
Registration of securities for employees
12:00am
6-K
CLLS
Cellectis
19 Sep 18
Cellectis S.a. 6-K
4:31pm
6-K
CLLS
Cellectis
18 Sep 18
Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP
12:00am
6-K
CLLS
Cellectis
22 Aug 18
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
2 Aug 18
Cellectis Appoints Stefan Scherer M.D., Ph.D., as Senior Vice President Clinical Development and Deputy Chief Medical Officer
4:30pm
6-K
CLLS
Cellectis
1 Aug 18
Current report (foreign)
5:04pm
6-K
CLLS
Cellectis
1 Aug 18
Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2018
5:03pm
6-K
CLLS
Cellectis
29 Jun 18
Current report (foreign)
4:31pm
6-K
CLLS
Cellectis
27 Jun 18
Cellectis S.A. Reports Results from Annual General Meeting
4:31pm